Volume 3, Issue 2
Hepatic tolerance study of aqueous extract of Mitracarpus scaber (Rubiaceae) in rabbits
Author(s): MDoumbia Idrissa*, Bagre Issa, Yapi Houphouet Felix, Djaman Allico Joseph, N’guessan Jean David
Abstract: This study aimed to evaluate the hepatic safety of Mitracarpus scaber (Rubiaceae) in rabbit. This plant is traditionally used for its antibacterial and antifungal properties. It is also used to treat skin diseases and many ailments in Côte d’Ivoire and around West Africa. Six groups of 6 rabbits each, were injected intraperitoneally, twice a week four six weeks, with increasing doses ranging from 12.5 to 200 mg/kg body weight of aqueous extract of Mitracarpus scaber (encoded Misca). Blood sampling was carried out to investigate changes in different serum biochemical markers: alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyltransferase (ᵧGT), lactate dehydrogenase (LDH), alkaline phosphatase (ALP), glucose, total proteins, total cholesterol, and triglycerides. The statistical analysis showed significant decrease of triglycerides concentration and in serum activities of ALP, LDH (P<0.05). But there is no significant change in serum activity of ALT, AST, ᵧGT as well as serum concentrations of glucose, total proteins and total cholesterol (P>0.05). In conclusion, the aqueous extract of Misca at dose of 100 mg/kg body weight for 4 weeks induces no hepatic dysfunction and is therefore well tolerated by the liver.
Download Full Article: Click Here
Support Us
If you are interested in supporting our work and would like to contribute, you are welcome to mail me at jpbr.anil@gmail.com or at info@thepharmajournal.com it will be a great help and will surely be appreciated.
